image

Prosecutors tell jury Theranos’ Holmes chose ‘fraud over business failure’

“She chose fraud over business failure. She chose to be dishonest,” Assistant U.S. Attorney Jeff Schenk said at the start of closing arguments. “That choice was not only callous, it was criminal.”

Holmes, 37, is on trial in San Jose, California, in a case that has shed light on Theranos’ failed endeavor to revolutionize lab testing with small machines that used only a few drops of blood.

Holmes’ attorney Kevin Downey told jurors at the start of his closing argument that the government’s case was misleading and incomplete.

“The picture can change quite a good deal as a result of waiting for the full story,” Downey said. He said prosecutors had not given them information about Theranos’ successful projects with drug companies, which were included in Holmes’ defense case.

Theranos was once valued at $9 billion and vaulted Holmes to Silicon Valley fame. Wealthy private investors including media mogul Rupert Murdoch invested millions in the company after meeting with the founder, who was known for her Steve Jobs-like black turtleneck.

Schenk, the prosecutor, recapped testimony from more than two dozen witnesses, including patients who had received inaccurate results from Theranos tests for HIV and cancer.

He recalled testimony from six investors that Holmes gave them false impressions that Theranos devices could carry out a broad range of tests and that they were being used by the U.S. military in the field.

Statements to investors and patients form the basis for nine counts of fraud.

Before finishing his argument, Schenk called on jurors to scrutinize Holmes’ testimony, during which they saw encouraging emails telling her the company’s technology worked. Holmes had also received emails with negative information from employees, including on test accuracy. But investors only heard the positive information, he said.

“There’s another word for that, and that’s intent,” he said.

Holmes conspired to commit those frauds with former Theranos chief operating officer Ramesh “Sunny” Balwani, Schenk said, with Holmes acting as the public face of Theranos and Balwani running its lab operations.

She also faces two counts of conspiracy.

The prosecutor told the jury that Holmes’ testimony that Balwani was abusive towards her in their romantic relationship was a separate matter from the charges at issue.

“You do not need to decide whether that abuse happened in order to reach a verdict,” he said. Balwani has denied the allegations.

Testifying in her own defense during the three-month trial, Holmes has said she did not intend to mislead anyone, and that the company’s laboratory directors were responsible for ensuring test accuracy.

Balwani, who is also charged with fraud and will stand trial separately, has pleaded not guilty.

Theranos collapsed after the Wall Street Journal published a series of articles starting in 2015 that suggested its devices were flawed and inaccurate. Holmes was indicted in 2018.


Source link

0 0 votes
Article Rating

S’abonner
Notifier de
0 Commentaires
Commentaires en ligne
Afficher tous les commentaires
Reset Password

Avertissement sur les risques :

Le trading peut vous exposer à des risques de pertes supérieures aux dépôts et ne convient qu’à une clientèle avisée ayant les moyens financiers de supporter un tel risque. Les CFD sont des instruments complexes et présentent un risque élevé de perte rapide en capital en raison de l’effet de levier. Entre 74 et 89% des comptes de clients de détail perdent de l’argent lors de la négociation de CFD. Vous devez vous assurer que vous comprenez comment les CFD fonctionnent et que vous pouvez vous permettre de prendre le risque élevé de perdre votre argent. Ce site n’est en aucun cas une offre de conseil en investissement ni une incitation quelconque à acheter ou vendre des instruments financiers. Trader le Forex et/ou les CFD’s implique un niveau de risque élevé, et peut ne pas être approprié car vous pouvez subir des pertes supérieures à votre dépôt. L’effet de levier peut être en votre défaveur.

Vous devez être conscient et avoir une compréhension complète de tous les risques associés au marché et au trading. Le site Union-trader.com peut être amené à produire des commentaires d’ordre général, ce qui ne constitue pas des conseils en investissement et ne doit pas être interprété comme tel.

Veuillez recourir aux conseils d’un conseiller financier extérieur. Le site Union-trader.com décline toute responsabilité pour les erreurs, inexactitudes ou omissions et ne garantit pas l’exactitude ou le caractère complet des informations, textes, graphiques, liens ou autres éléments contenus dans cette documentation. Toute information et toute mise à disposition sur le site ont un caractère privé.